SEX, LIES AND
PHARMACEUTICALS
RAY MOYNIHAN & DR. BARBARA MINTZES
SEX, LIES
+
PHARMACEUTICALS
HOW DRUG COMPANIES PLAN TO PROFIT FROM FEMALE SEXUAL DYSFUNCTION
D&M PUBLISHERS INC.
Vancouver/Toronto/Berkeley
Copyright © 2010 by Ray Moynihan
Chapter 5 Copyright © 2010 by Barbara Mintzes
First published by Allen & Unwin Pty Ltd,
83 Alexander Street, Crows Nest, Sydney, NSW, 2065, Australia
10 11 12 13 14 5 4 3 2 1
All rights reserved. No part of this book may be reproduced, stored
in a retrieval system or transmitted, in any form or by any means, without
the prior written consent of the publisher or a licence from The Canadian
Copyright Licensing Agency (Access Copyright). For a copyright licence,
visit www.accesscopyright.ca or call toll free to 1-800-893-5777.
Greystone Books
An imprint of D&M Publishers Inc.
2323 Quebec Street, Suite 201
Vancouver BC Canada V5T 4S7
Cataloguing data available from Library and Archives Canada
ISBN 978-1-55365-508-4 (pbk.)
ISBN 978-1-55365-652-4 (ebook)
Cover design by Jessica Sullivan
Cover photograph © Ashley Jouhar/cultura/Corbis
Printed and bound in Canada by Friesens
Text printed on acid-free, 100% post-consumer paper
Distributed in the U.S. by Publishers Group West
We gratefully acknowledge the financial support of the Canada Council
for the Arts, the British Columbia Arts Council, the Province of British
Columbia through the Book Publishing Tax Credit, and the Government of
Canada through the Canada Book Fund for our publishing activities.
For Toni, who is body surfing the waves of time with her turtle, adorned with the emu feathers falling from the stars . . . in celebration of your fearlessness and strength, your warmth and generosity, your laughter and love.
CONTENTS
Introduction: Sex, lies and pharmaceuticals
1 Difficulties or dvsfunctions?
3 Measuring pleasure
4 Educating doctors with ski trips and strip clubs
5 Viagra turns twelve
6 Premature prescriptions
7 Undoing the disorders
8 Looking ahead
Acknowledgements
Notes
Index
Sex seems to be how most of us got here, apart from the odd case of an immaculate conception or a miracle of medical technology. Sex is also something that—just like the weather— most of us are interested in, more or less. But just so you’re under no illusions, while this book is certainly about sex, it’s also an exposé of how medical science is imperceptibly merging with pharmaceutical marketing.
As a disclosure front and centre, for more than a decade I’ve been writing about the tangled web of relationships between doctors and drug companies, and the unhealthy impacts of that entanglement on people and public health systems. My coauthored 2005 book describing that problem, Selling Sickness: How drug companies are turning us all into patients, laid out ten case studies of disease-mongering: the process of widening the boundaries of illness in order to sell people more treatments. With humility and surprise, I can report that Selling Sickness has since been translated into twelve languages, and reprinted a number of times in North America and elsewhere.
In Sex, Lies and Pharmaceuticals the making of a single modern medical condition is forensically examined, and the resulting story is both fascinating and frightening. The book’s methods are those of rigorous investigative journalism, targeted at uncovering what happens behind the scenes of contemporary medical science. It draws on many scientific journal articles, medical textbooks, historic works of philosophy and sexuality, as well as some juicy corporate marketing materials and a few very revealing court documents.
I have also interviewed a long list of the key players in the emerging field called ‘sexual medicine’, spoken to professors, psychologists, bloggers, doctors and drug company insiders, and attended scientific seminars and medical meetings all over the world. The facts and evidence have been checked meticulously, and an extensive notes section has been included at the end of the book. I should apologise in advance to those who may feel there’s too much detail at certain points, but for others this will be the lifeblood of the story. And if you do find a factual error, please let us know so we can correct it in future editions.
Almost everyone approached for an interview agreed to speak with me, and their comments have been invaluable, with many appearing in direct quotations. While a tiny handful declined— as is noted when necessary—every effort has been made to fairly represent their viewpoints, which are readily available through their many publications and presentations.
It is important to say very clearly here that the book does not accuse anyone of lying. The ‘lies’ in the title refers to the fictions that flow from pharmaceutical marketing—like the notion that one in ten women suffers from a disorder of low desire. As we’ll see, soon that disorder itself may no longer even exist. The corporate need to market drugs for discrete disease labels does not match well with uncertainty over how to understand and classify women’s sexual difficulties.
One practical note for the reader is that the terms ‘dysfunction’, ‘disorder’ and ‘disease’